Psoriasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Psoriasis - Drugs In Development, 2022, provides an overview of the Psoriasis (Immunology) pipeline landscape.
Psoriasis is a chronic skin condition caused by an overactive immune system. Symptoms of the disease include shedding of cells, flared up skin, itchiness, and burning sensation, swollen and stiff joints. Predisposing factors include heredity, side effects of certain medicines, stress, infections and environmental conditions. The condition may be controlled by topical or systemic medications and phototherapy.
Report Highlights
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Psoriasis - Drugs In Development, 2022, provides comprehensive information on the therapeutics under development for Psoriasis (Immunology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Psoriasis (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Psoriasis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 12, 34, 47, 72, 7, 167, 39 and 9 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 6 and 5 molecules, respectively.
Psoriasis (Immunology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Psoriasis (Immunology).
- The pipeline guide reviews pipeline therapeutics for Psoriasis (Immunology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Psoriasis (Immunology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Psoriasis (Immunology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Psoriasis (Immunology)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Psoriasis (Immunology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Psoriasis (Immunology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Psoriasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Psoriasis - Overview
Psoriasis - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Psoriasis - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Psoriasis - Companies Involved in Therapeutics Development
Psoriasis - Drug Profiles
Psoriasis - Dormant Projects
Psoriasis - Discontinued Products
Psoriasis - Product Development Milestones
Featured News & Press Releases
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products under Development for Psoriasis, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Products under Development by Companies, 2022
Products under Development by Universities/Institutes, 2022
Number of Products by Stage and Target, 2022
Number of Products by Stage and Mechanism of Action, 2022
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Psoriasis - Pipeline by 3SBio Inc, 2022
Psoriasis - Pipeline by AbbVie Inc, 2022
Psoriasis - Pipeline by Abcentra LLC, 2022
Psoriasis - Pipeline by Abclon Inc, 2022
Psoriasis - Pipeline by Abivax SA, 2022
Psoriasis - Pipeline by Accro BioScience (Suzhou) Co Ltd, 2022
Psoriasis - Pipeline by Acelyrin Inc, 2022
Psoriasis - Pipeline by Aclaris Therapeutics Inc, 2022
Psoriasis - Pipeline by Actinobac Biomed Inc, 2022
Psoriasis - Pipeline by Aditxt Inc, 2022
Psoriasis - Pipeline by Affilogic SAS, 2022
Psoriasis - Pipeline by Akaal Pharma Pty Ltd, 2022
Psoriasis - Pipeline by Akeso Inc, 2022
Psoriasis - Pipeline by Aldeyra Therapeutics Inc, 2022
Psoriasis - Pipeline by Allergy Therapeutics Plc, 2022
Psoriasis - Pipeline by AltruBio Inc, 2022
Psoriasis - Pipeline by Aluda Pharmaceuticals Inc, 2022
Psoriasis - Pipeline by Alumis Inc, 2022
Psoriasis - Pipeline by Alvotech ehf, 2022
Psoriasis - Pipeline by Amgen Inc, 2022
Psoriasis - Pipeline by Amicogen Inc, 2022
Psoriasis - Pipeline by Amtixbio Co Ltd, 2022
Psoriasis - Pipeline by Amytrx Therapeutics Inc, 2022
Psoriasis - Pipeline by AnaptysBio Inc, 2022
Psoriasis - Pipeline by Annji Pharmaceutical Co Ltd, 2022
Psoriasis - Pipeline by AntalGenics SL, 2022
Psoriasis - Pipeline by AnTolRx Inc, 2022
Psoriasis - Pipeline by Apimeds Inc, 2022
Psoriasis - Pipeline by APIRx Pharmaceuticals USA LLC, 2022
Psoriasis - Pipeline by Applied Biology Inc, 2022
Psoriasis - Pipeline by Arbor Pharmaceuticals LLC, 2022
Psoriasis - Pipeline by Arcutis Biotherapeutics Inc, 2022
Psoriasis - Pipeline by Aristea Therapeutics Inc, 2022
Psoriasis - Pipeline by Arrien Pharmaceuticals LLC, 2022
Psoriasis - Pipeline by AstraZeneca Plc, 2022
Psoriasis - Pipeline by Athenex Inc, 2022
Psoriasis - Pipeline by Aurigene Discovery Technologies Ltd, 2022
Psoriasis - Pipeline by Avesthagen Ltd, 2022
Psoriasis - Pipeline by Avicanna Inc, 2022
Psoriasis - Pipeline by Avidin Biotechnology Ltd, 2022
Psoriasis - Pipeline by Avixgen Inc, 2022
Psoriasis - Pipeline by Avotres Inc, 2022
Psoriasis - Pipeline by Azora Therapeutics Australia Pty Ltd, 2022
Psoriasis - Pipeline by Bayer AG, 2022
Psoriasis - Pipeline by BCY Pharm Co Ltd, 2022
Psoriasis - Pipeline by Beijing FuKangren Bio-pharm Tech Co Ltd, 2022
Psoriasis - Pipeline by Beijing Guiqianjin Medical Technology Co Ltd, 2022
Psoriasis - Pipeline by Beijing Northland Biotech Co Ltd, 2022
Psoriasis - Pipeline by Beijing Scitech-MQ Pharmaceuticals Ltd, 2022
Psoriasis - Pipeline by Beijing SH biotechnology Co Ltd, 2022
Psoriasis - Pipeline by Bio-Thera Solutions Ltd, 2022
Psoriasis - Pipeline by BioApex sro, 2022
Psoriasis - Pipeline by Biocad, 2022
Psoriasis - Pipeline by Biocon Ltd, 2022
Psoriasis - Pipeline by BioFactura Inc, 2022
Psoriasis - Pipeline by Biogen Inc, 2022
Psoriasis - Pipeline by Biohaven Pharmaceutical Holding Company Ltd, 2022
Psoriasis - Pipeline by BioMarck Pharmaceuticals Ltd, 2022
Psoriasis - Pipeline by Biomendics LLC, 2022
Psoriasis - Pipeline by Biomimetix JV LLC, 2022
Psoriasis - Pipeline by Bioviz Technologies Pvt Ltd, 2022
Psoriasis - Pipeline by BioXpress Therapeutics SA, 2022
Psoriasis - Pipeline by Biozeus Pharmaceutical SA, 2022
Psoriasis - Pipeline by BirchBioMed Inc, 2022
Psoriasis - Pipeline by Boehringer Ingelheim International GmbH, 2022
Psoriasis - Pipeline by Boston Pharmaceuticals Inc, 2022
Psoriasis - Pipeline by Botanix Pharmaceuticals Ltd, 2022
Psoriasis - Pipeline by Brickell Biotech Inc, 2022
Psoriasis - Pipeline by Bristol-Myers Squibb Co, 2022
Psoriasis - Pipeline by Can-Fite BioPharma Ltd, 2022
Psoriasis - Pipeline by Cantargia AB, 2022
Psoriasis - Pipeline by Canvax Biotech SL, 2022
Psoriasis - Pipeline by Captor Therapeutics SA, 2022
Psoriasis - Pipeline by Caregen Co Ltd, 2022
Psoriasis - Pipeline by CellionBioMed Inc, 2022
Psoriasis - Pipeline by Cellivery Therapeutics Inc, 2022
Psoriasis - Pipeline by Cellix Bio Pvt Ltd, 2022
Psoriasis - Pipeline by Celltrion Inc, 2022
Psoriasis - Pipeline by Celon Pharma SA, 2022
Psoriasis - Pipeline by Centrymed Pharmaceutical Inc, 2022
Psoriasis - Pipeline by Changzhou Hengbang Pharmaceutical Co Ltd, 2022
Psoriasis - Pipeline by CheckPoint Immunology Inc, 2022
Psoriasis - Pipeline by ChemoCentryx Inc, 2022
Psoriasis - Pipeline by Chengdu Jinrui Foundation Biotechnology Co Ltd, 2022
Psoriasis - Pipeline by Chiesi Farmaceutici SpA, 2022
Psoriasis - Pipeline by Clonz Biotech Pvt Ltd, 2022
Psoriasis - Pipeline by Coegin Pharma AS, 2022
Psoriasis - Pipeline by Compugen Ltd, 2022
Psoriasis - Pipeline by Crescita Therapeutics Inc, 2022
Psoriasis - Pipeline by CSL Ltd, 2022
Psoriasis - Pipeline by CSPC Pharmaceutical Group Ltd, 2022
Psoriasis - Pipeline by Curapel Ltd, 2022
Psoriasis - Pipeline by Cythera Inc, 2022
Psoriasis - Pipeline by Cytodyn Inc, 2022
Psoriasis - Pipeline by Daewoong Pharmaceutical Co Ltd, 2022
Psoriasis - Pipeline by Daiichi Sankyo Co Ltd, 2022
Psoriasis - Pipeline by Dalriada Therapeutics Inc, 2022
Psoriasis - Pipeline by Deka Biosciences Inc, 2022
Psoriasis - Pipeline by DelArrivo Inc, 2022
Psoriasis - Pipeline by Denali Therapeutics Inc, 2022
Psoriasis - Pipeline by Derm-Biome Pharmaceuticals Inc, 2022
Psoriasis - Pipeline by Dermaliq Therapeutics Inc, 2022
Psoriasis - Pipeline by Dermata Therapeutics Inc, 2022
Psoriasis - Pipeline by Dermavant Sciences Inc, 2022
Psoriasis - Pipeline by DICE Therapeutics Inc, 2022
Psoriasis - Pipeline by DM Bio Ltd, 2022
Psoriasis - Pipeline by DNX Biopharmaceuticals Inc, 2022
Psoriasis - Pipeline by Dong-A ST Co Ltd, 2022
Psoriasis - Pipeline by Dr. August Wolff GmbH & Co KG Arzneimittel, 2022
Psoriasis - Pipeline by Dyve Biosciences Inc, 2022
Psoriasis - Pipeline by Eden Biologics Inc, 2022
Psoriasis - Pipeline by Egret Therapeutics Inc, 2022
Psoriasis - Pipeline by Eli Lilly and Co, 2022
Psoriasis - Pipeline by ELORAC Inc, 2022
Psoriasis - Pipeline by Enitiate Biopharmaceuticals (Hangzhou) Co Ltd, 2022
Psoriasis - Pipeline by Enzychem Lifesciences Corp, 2022
Psoriasis - Pipeline by Eolo Pharma, 2022
Psoriasis - Pipeline by Erganeo, 2022
Psoriasis - Pipeline by Escalier Biosciences BV, 2022
Psoriasis - Pipeline by Eternity Bioscience Inc, 2022
Psoriasis - Pipeline by Evelo Biosciences Inc, 2022
Psoriasis - Pipeline by Evommune Inc, 2022
Psoriasis - Pipeline by Exicure Inc, 2022
Psoriasis - Pipeline by Exogenus Therapeutics SA, 2022
Psoriasis - Pipeline by Formycon AG, 2022
Psoriasis - Pipeline by FunPep Co Ltd, 2022
Psoriasis - Pipeline by Galapagos NV, 2022
Psoriasis - Pipeline by Galectin Therapeutics Inc, 2022
Psoriasis - Pipeline by Generium, 2022
Psoriasis - Pipeline by GeneScience Pharmaceuticals Co Ltd, 2022
Psoriasis - Pipeline by Genesen Co Ltd, 2022
Psoriasis - Pipeline by Genor BioPharma Co Ltd, 2022
Psoriasis - Pipeline by Genosco Inc, 2022
Psoriasis - Pipeline by Genrix (Shanghai) Biopharmaceutical Co Ltd, 2022
Psoriasis - Pipeline by GlycoMar Ltd, 2022
Psoriasis - Pipeline by Green Cross LabCell Corp, 2022
Psoriasis - Pipeline by GSK plc, 2022
Psoriasis - Pipeline by Guangdong Yinzhu Pharmaceutical Technology Co Ltd, 2022
Psoriasis - Pipeline by Haisco Pharmaceutical Group Co Ltd, 2022
Psoriasis - Pipeline by HK inno.N Corp, 2022
Psoriasis - Pipeline by HLK Pharmacin LLC, 2022
Psoriasis - Pipeline by Hoth Therapeutics Inc, 2022
Psoriasis - Pipeline by Huabo Biopharm (Shanghai) Co Ltd, 2022
Psoriasis - Pipeline by Hualan Biological Engineering Inc, 2022
Psoriasis - Pipeline by Huaxia Source Cell Engineering Group Co Ltd, 2022
Psoriasis - Pipeline by ILC Therapeutics Ltd, 2022
Psoriasis - Pipeline by Iltoo Pharma, 2022
Psoriasis - Pipeline by IMD-Pharma SAS, 2022
Psoriasis - Pipeline by IMGENEX India Pvt Ltd, 2022
Psoriasis - Pipeline by Immune Pharmaceuticals Inc, 2022
Psoriasis - Pipeline by ImmuneMed Inc, 2022
Psoriasis - Pipeline by Immungenetics AG, 2022
Psoriasis - Pipeline by Immunic Inc, 2022
Psoriasis - Pipeline by ImmunoBiome Inc, 2022
Psoriasis - Pipeline by Immunwork Inc, 2022
Psoriasis - Pipeline by Impetis Biosciences Ltd, 2022
Psoriasis - Pipeline by Inflection Biosciences Ltd, 2022
Psoriasis - Pipeline by Inmagene Biopharmaceuticals Ltd, 2022
Psoriasis - Pipeline by InnoCare Pharma Ltd, 2022
Psoriasis - Pipeline by Innovent Biologics Inc, 2022
Psoriasis - Pipeline by Innovimmune Biotherapeutics Inc, 2022
Psoriasis - Pipeline by Instituto Biomar SA, 2022
Psoriasis - Pipeline by Io Therapeutics Inc, 2022
Psoriasis - Pipeline by Istesso Ltd, 2022
Psoriasis - Pipeline by J2H Biotech, 2022
Psoriasis - Pipeline by Japan Tobacco Inc, 2022
Psoriasis - Pipeline by Jiangsu Carephar Pharmaceutical Co Ltd, 2022
Psoriasis - Pipeline by Jiangsu Hengrui Medicine Co Ltd, 2022
Psoriasis - Pipeline by JiangSu Qyuns Therapeutics Co Ltd, 2022
Psoriasis - Pipeline by Johnson & Johnson, 2022
Psoriasis - Pipeline by JS InnoPharm (Shanghai) Ltd, 2022
Psoriasis - Pipeline by Jubilant Therapeutics Inc, 2022
Psoriasis - Pipeline by Kangpu Biopharmaceuticals Ltd, 2022
Psoriasis - Pipeline by Kine Sciences, 2022
Psoriasis - Pipeline by Kiniksa Pharmaceuticals Ltd, 2022
Psoriasis - Pipeline by KoBioLabs Inc, 2022
Psoriasis - Pipeline by Krystal Biotech Inc, 2022
Psoriasis - Pipeline by Kymab Ltd, 2022
Psoriasis - Pipeline by Landos Biopharma Inc, 2022
Psoriasis - Pipeline by Lead Pharma Holding BV, 2022
Psoriasis - Pipeline by Leo Pharma AS, 2022
Psoriasis - Pipeline by Link Health Group, 2022
Psoriasis - Pipeline by Lipidor AB, 2022
Psoriasis - Pipeline by Livzon Pharmaceutical Group Co Ltd, 2022
Psoriasis - Pipeline by Luye Pharma Group Ltd, 2022
Psoriasis - Pipeline by Lynk Pharmaceutical Hangzhou Co Ltd, 2022
Psoriasis - Pipeline by Mabpharm Ltd, 2022
Psoriasis - Pipeline by Machavert Pharmaceuticals LLC, 2022
Psoriasis - Pipeline by Maruho Co Ltd, 2022
Psoriasis - Pipeline by MC2 Therapeutics AS, 2022
Psoriasis - Pipeline by medac GmbH, 2022
Psoriasis - Pipeline by Medipure Pharmaceuticals Inc, 2022
Psoriasis - Pipeline by Meiji Seika Pharma Co Ltd, 2022
Psoriasis - Pipeline by Metrion Biosciences Ltd, 2022
Psoriasis - Pipeline by MetrioPharm AG, 2022
Psoriasis - Pipeline by Mical Pharmaceuticals LLC, 2022
Psoriasis - Pipeline by Midatech Pharma Plc, 2022
Psoriasis - Pipeline by MoonLake Immunotherapeutics, 2022
Psoriasis - Pipeline by Mycenax Biotech Inc, 2022
Psoriasis - Pipeline by Nanjing Aimeifei Biomedical Technology Co Ltd, 2022
Psoriasis - Pipeline by Nanjing Ruijie Pharmaceutical Technology Co Ltd, 2022
Psoriasis - Pipeline by NanoPharmaceuticals LLC, 2022
Psoriasis - Pipeline by Nektar Therapeutics, 2022
Psoriasis - Pipeline by Nepsone ehf, 2022
Psoriasis - Pipeline by NeuClone Pty Ltd, 2022
Psoriasis - Pipeline by Nimbus Therapeutics LLC, 2022
Psoriasis - Pipeline by NKGen Biotech Inc, 2022
Psoriasis - Pipeline by North China Pharmaceutical Group New Drug Research and Development Co Ltd, 2022
Psoriasis - Pipeline by NovaLead Pharma Pvt Ltd, 2022
Psoriasis - Pipeline by NovaRock Biotherapeutics Inc, 2022
Psoriasis - Pipeline by Numab Therapeutics AG, 2022
Psoriasis - Pipeline by Olys Pharma, 2022
Psoriasis - Pipeline by OncoSynergy Inc, 2022
Psoriasis - Pipeline by One World Cannabis Ltd, 2022
Psoriasis - Pipeline by Ono Pharmaceutical Co Ltd, 2022
Psoriasis - Pipeline by Orgenesis Inc, 2022
Psoriasis - Pipeline by Orphagen Pharmaceuticals Inc, 2022
Psoriasis - Pipeline by OSE Immunotherapeutics SA, 2022
Psoriasis - Pipeline by Outlook Therapeutics Inc, 2022
Psoriasis - Pipeline by Palo BioFarma SL, 2022
Psoriasis - Pipeline by Panaxia Pharmaceutical Industries Ltd, 2022
Psoriasis - Pipeline by Par'Immune SAS, 2022
Psoriasis - Pipeline by Paracrine Therapeutics Pte Ltd, 2022
Psoriasis - Pipeline by PB Immune Therapeutics Co Ltd, 2022
Psoriasis - Pipeline by Pfizer Inc, 2022
Psoriasis - Pipeline by Phaim Pharma Ltd, 2022
Psoriasis - Pipeline by Pharmapraxis, 2022
Psoriasis - Pipeline by PIQUR Therapeutics AG, 2022
Psoriasis - Pipeline by Polpharma Biologics SA, 2022
Psoriasis - Pipeline by PRCL Research Inc, 2022
Psoriasis - Pipeline by Precigen ActoBio Inc, 2022
Psoriasis - Pipeline by Principia Biopharma Inc, 2022
Psoriasis - Pipeline by Progenra Inc, 2022
Psoriasis - Pipeline by Protagonist Therapeutics Inc, 2022
Psoriasis - Pipeline by Protein Foundry LLC, 2022
Psoriasis - Pipeline by Protheragen Inc, 2022
Psoriasis - Pipeline by ProTransit Nanotherapy LLC, 2022
Psoriasis - Pipeline by Provectus Biopharmaceuticals Inc, 2022
Psoriasis - Pipeline by Pyramid Biosciences Inc, 2022
Psoriasis - Pipeline by Rebus Holdings Inc, 2022
Psoriasis - Pipeline by Regeneus Ltd, 2022
Psoriasis - Pipeline by Regranion LLC, 2022
Psoriasis - Pipeline by Reliance Life Sciences Pvt Ltd, 2022
Psoriasis - Pipeline by Revive Therapeutics Ltd, 2022
Psoriasis - Pipeline by Rigel Pharmaceuticals Inc, 2022
Psoriasis - Pipeline by Samsung Bioepis Co Ltd, 2022
Psoriasis - Pipeline by Sanofi, 2022
Psoriasis - Pipeline by Sareum Holdings Plc, 2022
Psoriasis - Pipeline by SBI Biotech Co Ltd, 2022
Psoriasis - Pipeline by Servatus Ltd, 2022
Psoriasis - Pipeline by SFA Therapeutics Inc, 2022
Psoriasis - Pipeline by Shandong Danhong Pharmaceutical Co Ltd, 2022
Psoriasis - Pipeline by Shanghai Celgen Bio-Pharmaceutical Co Ltd, 2022
Psoriasis - Pipeline by Shanghai Huiqi Biomedical Technology Co Ltd, 2022
Psoriasis - Pipeline by Shanghai Junshi Bioscience Co Ltd, 2022
Psoriasis - Pipeline by Shenzhen Chipscreen Biosciences Co Ltd, 2022
Psoriasis - Pipeline by Shulov Innovative Science Ltd, 2022
Psoriasis - Pipeline by Siam Bioscience Co Ltd, 2022
Psoriasis - Pipeline by Sienna Biopharmaceuticals Inc, 2022
Psoriasis - Pipeline by Simcere Pharmaceutical Group Ltd, 2022
Psoriasis - Pipeline by Singh Biotechnology LLC, 2022
Psoriasis - Pipeline by SinoCelltech Group Ltd, 2022
Psoriasis - Pipeline by siRNAgen Therapeutics Corp, 2022
Psoriasis - Pipeline by Sol-Gel Technologies Ltd, 2022
Psoriasis - Pipeline by Soligenix Inc, 2022
Psoriasis - Pipeline by Sublimity Therapeutics HoldCo Ltd, 2022
Psoriasis - Pipeline by Sun Pharma Advanced Research Company Ltd, 2022
Psoriasis - Pipeline by Sun Pharmaceutical Industries Ltd, 2022
Psoriasis - Pipeline by Sunny BioDiscovery Inc, 2022
Psoriasis - Pipeline by Suzhou Connect Biopharmaceuticals Ltd, 2022
Psoriasis - Pipeline by Suzhou Pharmavan Cancer Research Center Co Ltd, 2022
Psoriasis - Pipeline by Suzhou Zelgen Biopharmaceutical Co Ltd, 2022
Psoriasis - Pipeline by Syntrix Pharmaceuticals, 2022
Psoriasis - Pipeline by Technoderma Medicines Inc, 2022
Psoriasis - Pipeline by Temisis Therapeutics, 2022
Psoriasis - Pipeline by Tianjin Ever Union Biotechnology Co Ltd, 2022
Psoriasis - Pipeline by Tianjin Hemay Pharmaceutical Co Ltd, 2022
Psoriasis - Pipeline by TLL Pharmaceutical LLC, 2022
Psoriasis - Pipeline by Tonghua Dongbao Pharmaceutical Co Ltd, 2022
Psoriasis - Pipeline by UCB SA, 2022
Psoriasis - Pipeline by Union Therapeutics AS, 2022
Psoriasis - Pipeline by Usynova Pharmaceuticals Ltd, 2022
Psoriasis - Pipeline by Valin Technologies Ltd, 2022
Psoriasis - Pipeline by Ventyx Biosciences Inc, 2022
Psoriasis - Pipeline by Vidasym Inc, 2022
Psoriasis - Pipeline by Visionary Pharmaceuticals Inc, 2022
Psoriasis - Pipeline by Viva Vision Biotech, 2022
Psoriasis - Pipeline by vTv Therapeutics Inc, 2022
Psoriasis - Pipeline by Welichem Biotech Inc, 2022
Psoriasis - Pipeline by Wellstat Therapeutics Corp, 2022
Psoriasis - Pipeline by WntResearch AB, 2022
Psoriasis - Pipeline by Wuhan Institute of Biological Products Co Ltd, 2022
Psoriasis - Pipeline by Wuhan LL Science and Technology Development Co Ltd, 2022
Psoriasis - Pipeline by YIRUI Pharmaceutical Technology Co Ltd, 2022
Psoriasis - Pipeline by Zai Lab Ltd, 2022
Psoriasis - Dormant Projects, 2022
Psoriasis - Discontinued Products, 2022
List of Figures
Number of Products under Development for Psoriasis, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Number of Products by Top 10 Targets, 2022
Number of Products by Stage and Top 10 Targets, 2022
Number of Products by Top 10 Mechanism of Actions, 2022
Number of Products by Stage and Top 10 Mechanism of Actions, 2022
Number of Products by Top 10 Routes of Administration, 2022
Number of Products by Stage and Top 10 Routes of Administration, 2022
Number of Products by Top 10 Molecule Types, 2022
Number of Products by Stage and Top 10 Molecule Types, 2022
Global Thyroid Gland Disorders Treatment Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 80
Thyroid Gland Disorder Treatment is a kind of treatment method, which aims to The thyroid disorder patients, such as hypothyroidism patients and hyperthyroidism patients. When The thyroid gland does not produce sufficient hypothyroidism or too much hyperthyroidism, The body metabolism and functioning will be disrupted.
The global Thyroid Gland Disorders Treatment market was valued at US$ 2950 million in 2023 and is anticipated to reach US$ 3871.9 million by 2030, witnessing a CAGR o......
Global Brachytherapy Afterloaders, Brachytherapy Seeds Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 98
According to our LPI (LP Information) latest study, the global Brachytherapy Afterloaders, Brachytherapy Seeds market size was valued at US$ 150.8 million in 2023. With growing demand in downstream market, the Brachytherapy Afterloaders, Brachytherapy Seeds is forecast to a readjusted size of US$ 168.1 million by 2030 with a CAGR of 1.6% during review period.
The research report highlights the growth potential of the global Brachytherapy Afterloaders, Brachytherapy Seeds market. Brachyth......
Global Peptide Therapeutics Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 109
According to our LPI (LP Information) latest study, the global Peptide Therapeutics market size was valued at US$ 33800 million in 2023. With growing demand in downstream market, the Peptide Therapeutics is forecast to a readjusted size of US$ 63130 million by 2030 with a CAGR of 9.3% during review period.
The research report highlights the growth potential of the global Peptide Therapeutics market. Peptide Therapeutics are expected to show stable growth in the future market. However, pr......
Global Microbiome Therapeutics Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 155
According to our LPI (LP Information) latest study, the global Microbiome Therapeutics market size was valued at US$ 89 million in 2023. With growing demand in downstream market, the Microbiome Therapeutics is forecast to a readjusted size of US$ 916.3 million by 2030 with a CAGR of 39.5% during review period.
The research report highlights the growth potential of the global Microbiome Therapeutics market. Microbiome Therapeutics are expected to show stable growth in the future market. H......
Global Anti-inflammatory Therapeutics Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 109
According to our LPI (LP Information) latest study, the global Anti-inflammatory Therapeutics market size was valued at US$ 108140 million in 2023. With growing demand in downstream market, the Anti-inflammatory Therapeutics is forecast to a readjusted size of US$ 166150 million by 2030 with a CAGR of 6.3% during review period.
The research report highlights the growth potential of the global Anti-inflammatory Therapeutics market. Anti-inflammatory Therapeutics are expected to show stabl......
Global Enzyme Replacement Therapy Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 113
According to our LPI (LP Information) latest study, the global Enzyme Replacement Therapy market size was valued at US$ 11570 million in 2023. With growing demand in downstream market, the Enzyme Replacement Therapy is forecast to a readjusted size of US$ 29900 million by 2030 with a CAGR of 14.5% during review period.
The research report highlights the growth potential of the global Enzyme Replacement Therapy market. Enzyme Replacement Therapy are expected to show stable growth in the f......
Global Infantile Spasms Therapeutics Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 84
According to our LPI (LP Information) latest study, the global Infantile Spasms Therapeutics market size was valued at US$ 138.9 million in 2023. With growing demand in downstream market, the Infantile Spasms Therapeutics is forecast to a readjusted size of US$ 179.6 million by 2030 with a CAGR of 3.7% during review period.
The research report highlights the growth potential of the global Infantile Spasms Therapeutics market. Infantile Spasms Therapeutics are expected to show stable grow......
Global Hormone Replacement Therapy Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 128
According to our LPI (LP Information) latest study, the global Hormone Replacement Therapy market size was valued at US$ 16090 million in 2023. With growing demand in downstream market, the Hormone Replacement Therapy is forecast to a readjusted size of US$ 17930 million by 2030 with a CAGR of 1.6% during review period.
The research report highlights the growth potential of the global Hormone Replacement Therapy market. Hormone Replacement Therapy are expected to show stable growth in th......
Global Plasma Therapy Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 107
According to our LPI (LP Information) latest study, the global Plasma Therapy market size was valued at US$ 265.3 million in 2023. With growing demand in downstream market, the Plasma Therapy is forecast to a readjusted size of US$ 529.4 million by 2030 with a CAGR of 10.4% during review period.
The research report highlights the growth potential of the global Plasma Therapy market. Plasma Therapy are expected to show stable growth in the future market. However, product differentiation, ......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
